产品展示
PRO-317 Factor-VIII Human/人八因子
点击次数：190发布时间：2012/7/23 16:23:02
更新日期：2024/10/16 15:58:55
所 在 地：美洲
产品型号：
优质供应
详细内容
厦门慧嘉生物专业销售PRO-317 Factor-VIII Human/人八因子 Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec peprotech细胞因子特价。等生物试剂产品。实验为大，诚信经营，为客户提供“质量的产品”和“质的服务"QQ: 1193953234 1048735792 或登陆（向客服人员索取原版说明书） http://www.biohj.com 欢迎广大老师来询！
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Factor-VIII Human/人八因子
产品编号：PRO-317
产品规格：200IU/400IU/600IU
Synonyms Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. Introduction Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. Description Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency.
The Factor-VIII is purified by proprietary chromatographic techniques. Source Human Plasma. Physical Appearance Sterile Filtered White lyophilized （freeze-dried） powder. Formulation The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. Solubility It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions.
Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. Stability Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. Biological Activity The potency per mg was tested ａnd found to be 150 Units/mg. Human Virus Test The plasma is collected from donors with Hepatitis B vaccinated.
Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
产品规格：200IU/400IU/600IU
| Synonyms | Coagulation factor VIII, Procoagulant component, Antihemophilic factor, AHF, F8, F8C, F8B, HEMA, FVIII, DXS1253E, F8 protein. |
| Introduction | Coagulation factor VIII participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 ａnd phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma ａnd associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. |
| Description | Human Facor VIII produced from Human Plasma is effective in the correction ａnd prevention of severe bleeding episodes attributed to Factor VIII deficiency. The Factor-VIII is purified by proprietary chromatographic techniques. |
| Source | Human Plasma. |
| Physical Appearance | Sterile Filtered White lyophilized （freeze-dried） powder. |
| Formulation | The lyophilized protein 200IU/ml was lyophilized from a sterile solution containing 1.5% Glycine, 160mM Calcium chloride ａnd 25mM NaCitrate ａnd 25mM NaCl. |
| Solubility | It is recommended to reconstitute the lyophilized Factor-VIII in sterile 18MΩ-cm H2O at a concentration of 200IU/ml, which can then be further diluted to other aqueous solutions. Make sure that the vial has reached room temperature prior to its reconstitution, otherwise it might precipitate. |
| Stability | Lyophilized Factor-VIII although stable at room temperature for 1 week, should be stored desiccated between 2-8°C. Upon reconstitution Factor-VIII should be storedat 4°C. |
| Biological Activity | The potency per mg was tested ａnd found to be 150 Units/mg. |
| Human Virus Test | The plasma is collected from donors with Hepatitis B vaccinated. Each unit of plasma has been tested for HBsAg, Anti-HIV-1/2 plus O ａnd Anti-HCV by using the imported kits which are approved by Federal Drug Administration （FDA）. |
| Usage | Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
